Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Clinical trial NCT01134562 · COMPLETED

Trial details

NCT number: NCT01134562
Sponsor: KAI Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hyperparathyroidism, Secondary

Start date: 2010-09-07
Primary completion: 2011-04-02
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.